A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01711671 · COMPLETED
Trial details
- NCT number
- NCT01711671
- Sponsor
- Leap Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.